Jonathan D. Campbell

8.0k total citations · 2 hit papers
121 papers, 4.1k citations indexed

About

Jonathan D. Campbell is a scholar working on Economics and Econometrics, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jonathan D. Campbell has authored 121 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Economics and Econometrics, 22 papers in Physiology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jonathan D. Campbell's work include Health Systems, Economic Evaluations, Quality of Life (40 papers), Asthma and respiratory diseases (21 papers) and Pharmaceutical Economics and Policy (19 papers). Jonathan D. Campbell is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (40 papers), Asthma and respiratory diseases (21 papers) and Pharmaceutical Economics and Policy (19 papers). Jonathan D. Campbell collaborates with scholars based in United States, United Kingdom and Thailand. Jonathan D. Campbell's co-authors include Piyameth Dilokthornsakul, Melanie D. Whittington, R. Brett McQueen, Sean D. Sullivan, Nicholas G. LaRocca, Lorene M. Nelson, Helen Tremlett, Ruth Ann Marrie, Annette Langer‐Gould and Mitchell T. Wallin and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Neurology.

In The Last Decade

Jonathan D. Campbell

111 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The prevalence of MS in the United States

2019 779 citations Jonathan D. Campbell, Piyameth Dilokthornsakul et al. profile →
Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study

2015 413 citations Jonathan D. Campbell, Sally E. Wenzel et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan D. Campbell United States	32	969	940	928	600	419	121	4.1k
Elizabeth Williamson United Kingdom	39	583 0.6×	580 0.6×	1.3k 1.5×	468 0.8×	700 1.7×	132	7.2k
Stephen P. McKenna United Kingdom	38	446 0.5×	818 0.9×	310 0.3×	773 1.3×	529 1.3×	154	6.0k
Laura Trupin United States	49	688 0.7×	998 1.1×	720 0.8×	293 0.5×	501 1.2×	171	6.8k
Tom Palmer United Kingdom	33	742 0.8×	394 0.4×	421 0.5×	203 0.3×	930 2.2×	90	5.9k
Tatyana Shamliyan United States	36	669 0.7×	362 0.4×	569 0.6×	579 1.0×	614 1.5×	111	5.7k
Martha Bayliss United States	30	541 0.6×	302 0.3×	708 0.8×	481 0.8×	1.4k 3.3×	60	5.5k
Paola Mosconi Italy	36	361 0.4×	648 0.7×	610 0.7×	510 0.8×	673 1.6×	138	6.1k
Joshua F. Baker United States	39	749 0.8×	464 0.5×	743 0.8×	136 0.2×	730 1.7×	219	5.1k
Gabriel Baron France	43	1.3k 1.4×	779 0.8×	535 0.6×	431 0.7×	1.7k 4.1×	117	8.4k
Sofía Ramiro Netherlands	44	387 0.4×	1.0k 1.1×	493 0.5×	317 0.5×	372 0.9×	281	7.5k

Countries citing papers authored by Jonathan D. Campbell

Since Specialization

Citations

This map shows the geographic impact of Jonathan D. Campbell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan D. Campbell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan D. Campbell more than expected).

Fields of papers citing papers by Jonathan D. Campbell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan D. Campbell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan D. Campbell. The network helps show where Jonathan D. Campbell may publish in the future.

Co-authorship network of co-authors of Jonathan D. Campbell

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan D. Campbell. A scholar is included among the top collaborators of Jonathan D. Campbell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan D. Campbell. Jonathan D. Campbell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Patterson, Julie A., et al.. (2025). Early impact of the Inflation Reduction Act on small molecule vs biologic post-approval oncology trials. Health Affairs Scholar. 3(8). qxaf152–qxaf152.

Campbell, Jonathan D., et al.. (2025). US Drug Pricing Patterns Before Loss of Exclusivity. Value in Health. 28(6). 907–914.

Nagy, Balàzs, Ahmad Nader Fasseeh, Jonathan D. Campbell, et al.. (2024). Tradeoffs When Building and Running Cohort and Patient-Level Markov Simulation Models. Algorithms. 17(12). 546–546.

Lin, Grace A., et al.. (2023). Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: Effectiveness and value. Journal of Managed Care & Specialty Pharmacy. 29(7). 857–861. 6 indexed citations

Campbell, Jonathan D., et al.. (2022). HTA8 The Relationship between ICER's Evidence Rating Matrix and Incremental Quality-Adjusted Life Years. Value in Health. 25(7). S505–S505. 1 indexed citations

Gurfinkel, Dennis, Allison Kempe, Christina Albertin, et al.. (2021). Centralized Reminder/Recall for Human Papillomavirus Vaccination: Findings From Two States—A Randomized Clinical Trial. Journal of Adolescent Health. 69(4). 579–587. 12 indexed citations

Szilagyi, Peter G., Christina Albertin, Alison W. Saville, et al.. (2020). Effect of State Immunization Information System Based Reminder/Recall for Influenza Vaccinations: A Randomized Trial of Autodialer, Text, and Mailed Messages. The Journal of Pediatrics. 221. 123–131.e4. 14 indexed citations

Kempe, Allison, Alison W. Saville, Christina Albertin, et al.. (2019). Centralized Reminder/Recall to Increase Influenza Vaccination Rates: A Two-State Pragmatic Randomized Trial. Academic Pediatrics. 20(3). 374–383. 10 indexed citations

Dilokthornsakul, Piyameth, Angela Thompson, & Jonathan D. Campbell. (2018). Treatment patterns and related clinical consequences in adults with asthma. Journal of Asthma. 56(7). 739–747. 3 indexed citations

10.

Dilokthornsakul, Piyameth, et al.. (2017). Forecasting the Long-Term Clinical and Economic Outcomes of Lumacaftor/Ivacaftor in Cystic Fibrosis Patients with Homozygous phe508del Mutation. Value in Health. 20(10). 1329–1335. 10 indexed citations

11.

Sullivan, Patrick W., Gary Globe, Vahram Ghushchyan, et al.. (2016). Exploring asthma control cutoffs and economic outcomes using the Asthma Control Questionnaire. Annals of Allergy Asthma & Immunology. 117(3). 251–257.e2. 6 indexed citations

12.

Campbell, Courtney, Jonathan D. Campbell, Christopher H. Thompson, et al.. (2013). Selective Targeting of Gain-of-Function KCNQ1 Mutations Predisposing to Atrial Fibrillation. Circulation Arrhythmia and Electrophysiology. 6(5). 960–966. 22 indexed citations

13.

Campbell, Jonathan D., Felicia Allen‐Ramey, Shiva G. Sajjan, Eric M. Maiese, & Sean D. Sullivan. (2011). Increasing pharmaceutical copayments: impact on asthma medication utilization and outcomes.. PubMed. 17(10). 703–10. 29 indexed citations

14.

Ghushchyan, Vahram, Jonathan D. Campbell, & Anne M. Libby. (2011). PMH44 PHYSICAL AND MENTAL HEALTH AS IMPORTANT INPUTS INTO WAGE FUNCTION. Value in Health. 14(3). A193–A193. 1 indexed citations

15.

Campbell, Jonathan D., Eldon Spackman, & Sean D. Sullivan. (2010). The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspective. Allergy. 65(9). 1141–1148. 73 indexed citations

16.

Hollingworth, William, Jonathan D. Campbell, Jonathan W. Kowalski, et al.. (2010). Exploring the impact of changes in neurogenic urinary incontinence frequency and condition-specific quality of life on preference-based outcomes. Quality of Life Research. 19(3). 323–331. 14 indexed citations

17.

Campbell, Jonathan D., Larry Borish, Tmirah Haselkorn, et al.. (2008). The response to combination therapy treatment regimens in severe/difficult-to-treat asthma. European Respiratory Journal. 32(5). 1237–1242. 13 indexed citations

18.

Kulich, Michal, Margaret Rosenfeld, Jonathan D. Campbell, et al.. (2005). Disease-specific Reference Equations for Lung Function in Patients with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 172(7). 885–891. 50 indexed citations

19.

Brody, Alan S., Heidi Sucharew, Jonathan D. Campbell, et al.. (2005). Computed Tomography Correlates with Pulmonary Exacerbations in Children with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 172(9). 1128–1132. 116 indexed citations

20.

Campbell, Jonathan D., et al.. (1981). Special Award of Appreciation Presented to Claude J. Cruse, Executive Secretary. Journal of Dairy Science. 64(9). 1897–1897.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact